Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ibrutinib Inhibits BMX-Dependent Endothelial VCAM-1 Expression In Vitro and Pro-Atherosclerotic Endothelial Activation and Platelet Adhesion In Vivo.
Kohs TCL, Olson SR, Pang J, Jordan KR, Zheng TJ, Xie A, Hodovan J, Muller M, McArthur C, Johnson J, Sousa BB, Wallisch M, Kievit P, Aslan JE, Seixas JD, Bernardes GJL, Hinds MT, Lindner JR, McCarty OJT, Puy C, Shatzel JJ. Kohs TCL, et al. Among authors: zheng tj. Cell Mol Bioeng. 2022 Apr 18;15(3):231-243. doi: 10.1007/s12195-022-00723-1. eCollection 2022 Jun. Cell Mol Bioeng. 2022. PMID: 35611166 Free PMC article.
The Toll-Like Receptor 2 Ligand Pam2CSK4 Activates Platelet Nuclear Factor-κB and Bruton's Tyrosine Kinase Signaling to Promote Platelet-Endothelial Cell Interactions.
Parra-Izquierdo I, Lakshmanan HHS, Melrose AR, Pang J, Zheng TJ, Jordan KR, Reitsma SE, McCarty OJT, Aslan JE. Parra-Izquierdo I, et al. Among authors: zheng tj. Front Immunol. 2021 Aug 30;12:729951. doi: 10.3389/fimmu.2021.729951. eCollection 2021. Front Immunol. 2021. PMID: 34527000 Free PMC article.
Thrombotic events in patients using cyclin dependent kinase 4/6 inhibitors, analysis of existing ambulatory risk assessment models and the potential influences of tumor specific risk factors.
West MT, Kartika T, Paquin AR, Liederbauer E, Zheng TJ, Lane L, Thein K, Shatzel JJ. West MT, et al. Among authors: zheng tj. Curr Probl Cancer. 2022 Apr;46(2):100832. doi: 10.1016/j.currproblcancer.2021.100832. Epub 2022 Jan 10. Curr Probl Cancer. 2022. PMID: 35034766 Free PMC article. Review.
Effect of antiplatelet agents and tyrosine kinase inhibitors on oxLDL-mediated procoagulant platelet activity.
Zheng TJ, Kohs TCL, Mueller PA, Pang J, Reitsma SE, Parra-Izquierdo I, Melrose AR, Yang L, Choi J, Zientek KD, Sviridov DO, Larson MK, Williams CD, Pamir N, Shatzel JJ, Reddy AP, Kievit P, Remaley AT, Stevens JF, Hinds MT, McCarty OJT, Aslan JE. Zheng TJ, et al. Blood Adv. 2023 Apr 25;7(8):1366-1378. doi: 10.1182/bloodadvances.2022007169. Blood Adv. 2023. PMID: 36219587 Free PMC article.
19 results